Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening

Li Ching Ooi, Nobumoto Watanabe*, Yushi Futamura, Shaida Fariza Sulaiman, Ibrahim Darah, Hiroyuki Osada

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)


Dysregulation of p27Kip1 due to proteolysis that involves the ubiquitin ligase (SCF) complex with S-phase kinase-associated protein 2 (Skp2) as the substrate-recognition component (SCFSkp2) frequently results in tumorigenesis. In this report, we developed a high-throughput screening system to identify small-molecule inhibitors of p27Kip1 degradation. This system was established by tagging Skp2 with fluorescent monomeric Azami Green (mAG) and CDK subunit 1 (Cks1) (mAGSkp2-Cks1) to bind to p27Kip1 phosphopeptides. We identified two compounds that inhibited the interaction between mAGSkp2-Cks1 and p27Kip1: linichlorin A and gentian violet. Further studies have shown that the compounds inhibit the ubiquitination of p27Kip1 in vitro as well as p27Kip1 degradation in HeLa cells. Notably, both compounds exhibited preferential antiproliferative activity against HeLa and tsFT210 cells compared with NIH3T3 cells and delayed the G1 phase progression in tsFT210 cells. Our approach indicates a potential strategy for restoring p27Kip1 levels in human cancers.

Original languageEnglish
Pages (from-to)1461-1467
Number of pages7
JournalCancer Science
Issue number11
Publication statusPublished - 2013 Nov
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening'. Together they form a unique fingerprint.

Cite this